HOME >> MEDICINE >> NEWS
Therapy is not one size fits all

COLUMBIA, Mo. - The new school of thought is that there is not just one correct school of thought when it comes to counseling people. In actual practice, therapists mix theories and methods in order to produce best practices for helping clients. Experienced therapists tend to base their practices upon the core processes that define psychotherapy across the theories. However, textbooks are still divided into specific theories.

A new book, written by two University of Missouri-Columbia experts, aims to revolutionize the way psychotherapy is taught and break the pattern. These scholars encourage students to recognize that the strength of the therapeutic relationship is highly associated with therapeutic outcome, and that therapy proceeds through the basic stages: engagement, pattern, search, change and termination.

"Traditionally, psychotherapy has been driven by specific theoretical orientations and their corresponding techniques. However, these specific orientations rarely coincide well with the needs of clients," said Glenn Good, associate professor of educational, school and counseling psychology in the MU College of Education. "Complex theories often have very limited application."

Only about a third of all people who seek therapy have a favorable outcome to the first intervention, according to Good. It is important for therapists to have a variety of ways to treat people.

"A therapist stuck in just one school of thought is not going to have enough tools to help every client," Good said. "We are not trying to sell a Ford, Chevy or Toyota. We are just trying to make the best car we can, and that is good therapy."

A client may seek therapy because a series of set backs in life. The client may be discouraged or depressed because the future seems bleak. Drinking may be the short-term solution being used to combat anxiety in this situation.

"This client does not need to have their childhood experience
'"/>

Contact: Jennifer Faddis
faddisj@missouri.edu
573-882-6217
University of Missouri-Columbia
4-Apr-2007


Page: 1 2

Related medicine news :

1. Therapy program export treats borderline personality disorder
2. Innovative Cancer Therapy for Tomorrow
3. MGH named by NHLBI as Specialized Center for Cell-Based Therapy for Heart, Lung and Blood Diseases
4. Therapy may not be necessary for autoimmune hepatitis with no symptoms
5. Therapy to overcome fears helps children with obsessive-compulsive disorder

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Therapy not one size fits all

(Date:5/18/2013)... 18, 2013 Scott Tischler of Tischler Brothers ... These five keys to losing weight played a huge part ... of Scott Tischler, Troy was able to lose a pound ... loss program should be approached with caution and any activity ... the five keys to weight loss that Scott Tischler advocates. ...
(Date:5/18/2013)... May 18, 2013 Wine World Accessories, ... offering its customers an attractive 25% discount on Franmara ... , Customers can now purchase this electric corkscrew opener ... online transactional process. The online store ensures delivery of ... of order placement. , A spokesperson from the ...
(Date:5/18/2013)... the the Stevens Johnson Syndrome Foundation, Stevens Johnson Syndrome (SJS), ... reaction usually to medicine (i). The first signs of ... blistering and large areas of dead skin. Some severe ... any time and seriously affect both children and adults. ... after he received kidney medicine which caused SJS (ii). ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Three new ... two health and wellness centers and one therapeutic dispensary. ... three locations, the weekend of May 25th – May ... celebrating Memorial Day. All events will take ... May 25th , Elements Therapeutic Dispensary , 10580 S. ...
(Date:5/17/2013)... 2013 Orriant is flexing its ... to businesses across the U.S. with an enhanced ... rigorous infrastructure upgrades for their telecommunications platform, which ... via voice and data. As a company ... healthcare costs and take advantage of federal ...
Breaking Medicine News(10 mins):Health News:Now Save 25% on Franmara Dynamo Electric Wine Bottle Opener at Wine World Accessories 2Health News:Injury Law Firm Announces New Informative Graphic on Common Medicines That Have Allegedly Been Linked to Stevens Johnson Syndrome 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 3Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 4Health News:New Telecommunications Upgrade Provides More Capacity for National Corporate Wellness Programs offered by Orriant 2
(Date:5/17/2013)... May 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 ... in both dose groups. The primary endpoint assessed the ... Consistent with data reported in previous trials, the most ... Full results will be presented at an upcoming medical ...
(Date:5/17/2013)... Biotech Ltd. (Nasdaq: SVA ), a leading provider ... that it will release its unaudited financial results for the ... May 28, 2013.  The Company will host a conference call ... 28, 2013 at 8:00 p.m. China Standard Time) to review ... corporate developments. To access the conference call, please ...
(Date:5/16/2013)... and ZURICH , May 17, 2013 ... for Science, Technology and Research (A*STAR) and Switzerland,s ... healthy volunteer has been dosed in a Phase 1 clinical ... proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In this first ... novel vaccine candidate and its potential to protect against H1N1 ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
Cached News: